8:55am ET
Health and Healthcare
Big Pharma Short Sellers Get Selective
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Companies
/Healthcare
Lilly(Eli) & Company
$1,160.00
▲ $3.27 (+0.28%) today
Markets closed · 8:11am ET
LLY Coverage
Page 207:55am ET
Health and Healthcare
Allergan Gets FDA Approval for Migraine Treatment
The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released…
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Datadog, Delta Air, Eli Lilly, FedEx, Halliburton, Kinder Morgan, Skechers, Teladoc, Waste Management and More
Wednesday's top analyst upgrades, downgrades and initiations included Activision Blizzard, Datadog, Delta Air Lines, Eli Lilly, FedEx, Halliburton, Kinder Morgan, Skechers, Teladoc and Waste Management.
9:45am ET
Health and Healthcare
Big Pharma Short Sellers Grow More Selective
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
9:00am ET
Health and Healthcare
Big Pharma Short Sellers Hike Their Bets
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
8:50am ET
Health and Healthcare
Big Pharma Scares Off Short Sellers
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
9:59am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
10:25am ET
Health and Healthcare
Eli Lilly Just Couldn’t Get It Together in Q3
Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.
Chris Lange 6:45am ET
Health and Healthcare
How Biotech and Big Pharma Have Upside Heading Into Earnings
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
12:10pm ET
Health and Healthcare
Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
Chris Lange 10:45am ET
Health and Healthcare
Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.